These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 952988)
1. Triacylglycerol contents and in vivo lipogenesis of ob/ob, db/db and Avy/a mice. Yen TT; Allan JA; Yu PL; Acton MA; Pearson DV Biochim Biophys Acta; 1976 Aug; 441(2):213-20. PubMed ID: 952988 [TBL] [Abstract][Full Text] [Related]
2. Morphometric analysis of obesity (ob/ob)- and diabetes (db/db)-associated hypothalamic neuronal degeneration in C57BL/KsJ mice. Garris DR Brain Res; 1989 Oct; 501(1):162-70. PubMed ID: 2804691 [TBL] [Abstract][Full Text] [Related]
3. Cytochemical analysis of pancreatic islet hypercytolipidemia following diabetes (db/db) and obese (ob/ob) mutation expression: influence of genomic background. Garris DR; Garris BL Pathobiology; 2004; 71(5):231-40. PubMed ID: 15459481 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of dehydroepiandrosterone (DHEA) and its metabolites in obese-hyperglycemic mutant mice. Coleman DL Prog Clin Biol Res; 1988; 265():161-75. PubMed ID: 2970093 [TBL] [Abstract][Full Text] [Related]
5. Control of obesity in Avy/a mice by 5alpha-androstan-17-one. Yen TT; Allan JA; Pearson DV; Acton JM Experientia; 1978 Dec; 34(12):1542-3. PubMed ID: 729710 [TBL] [Abstract][Full Text] [Related]
6. Obesity in db and ob animals leads to impaired hepatic very low density lipoprotein secretion and differential secretion of apolipoprotein B-48 and B-100. Li X; Grundy SM; Patel SB J Lipid Res; 1997 Jul; 38(7):1277-88. PubMed ID: 9254055 [TBL] [Abstract][Full Text] [Related]
7. The antiobesity and metabolic activities of LY79771 in obese and normal mice. Yen TT Int J Obes; 1984; 8(1):69-78. PubMed ID: 6368435 [TBL] [Abstract][Full Text] [Related]
8. Substance P, neurokinin A, vasoactive intestinal polypeptide and gastrin releasing peptide in the intestine and pancreas of spontaneously obese-diabetic mice. Bailey CJ; Flatt PR; Deacon CF; Shaw C; Conlon JM Regul Pept; 1986 Dec; 16(3-4):339-48. PubMed ID: 2436255 [TBL] [Abstract][Full Text] [Related]
9. Lipogenesis in genetically diabetic (db/db) mice: developmental changes in brown adipose tissue, white adipose tissue and the liver. Trayhurn P; Wusteman MC Biochim Biophys Acta; 1990 Nov; 1047(2):168-74. PubMed ID: 2248973 [TBL] [Abstract][Full Text] [Related]
10. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats. Chang AY; Wyse BM; Gilchrist BJ; Peterson T; Diani AR Diabetes; 1983 Sep; 32(9):830-8. PubMed ID: 6354790 [TBL] [Abstract][Full Text] [Related]
11. Effect of genetic background on the therapeutic effects of dehydroepiandrosterone (DHEA) in diabetes-obesity mutants and in aged normal mice. Coleman DL; Schwizer RW; Leiter EH Diabetes; 1984 Jan; 33(1):26-32. PubMed ID: 6228478 [TBL] [Abstract][Full Text] [Related]
12. Immunoreactive neurotensin in spontaneous syndromes of obesity and diabetes in mice. Sheppard MC; Bailey CJ; Flatt PR; Swanston-Flatt SK; Shennan KI Acta Endocrinol (Copenh); 1985 Apr; 108(4):532-6. PubMed ID: 3887830 [TBL] [Abstract][Full Text] [Related]